He is the inpatient neurology consultant for the Specialized Huntington’s Disease Unit at Tewksbury State Hospital and has active HD clinics at Boston University and the Boston Veterans Administration Hospital. He is the site Principal Investigator for 2CARE, and the recently completed COHORT and PHAROS studies. He played a key role in the recent studies used to obtain FDA approval for tetrabenazine use for chorea. Dr. Frank is also an active member of the New England HDSA Family services committee and the National HDSA Education Committee.